These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14502799)

  • 1. Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6.
    Abrahams NA; Bostwick DG; Ormsby AH; Qian J; Brainard JA
    Am J Clin Pathol; 2003 Sep; 120(3):368-76. PubMed ID: 14502799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
    Coogan CL; Bostwick DG; Bloom KJ; Gould VE
    Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma].
    Kong X; Deng F; Wang J
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):199-201. PubMed ID: 9275650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.
    Cheville JC; Bostwick DG
    Am J Surg Pathol; 1995 Sep; 19(9):1068-76. PubMed ID: 7544958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
    Egan AJ; Lopez-Beltran A; Bostwick DG
    Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach.
    Helpap B
    Virchows Arch; 1998 Nov; 433(5):397-405. PubMed ID: 9849853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Santinelli A; Mazzucchelli R
    Panminerva Med; 2002 Sep; 44(3):213-20. PubMed ID: 12094135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histomorphological study of prostatic adenocarcinoma and its mimics.
    Mahapatra QS; Mohanty P; Nanda A; Mohanty L
    Indian J Pathol Microbiol; 2019; 62(2):251-260. PubMed ID: 30971549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
    Chen YB; Fine SW; Epstein JI
    Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases.
    Wojno KJ; Epstein JI
    Am J Surg Pathol; 1995 Mar; 19(3):251-60. PubMed ID: 7532918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological features of prostate cancer].
    Kozuka Y; Imai H; Yamanaka M; Kozuka M; Uchida K; Shiraishi T
    Nihon Rinsho; 2005 Feb; 63(2):231-6. PubMed ID: 15714971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precursor lesions to prostatic adenocarcinoma.
    Epstein JI
    Virchows Arch; 2009 Jan; 454(1):1-16. PubMed ID: 19048290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG; Qian J; Maihle NJ
    Prostate; 2004 Feb; 58(2):164-8. PubMed ID: 14716741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of androgen deprivation therapy on prostatic intraepithelial neoplasia.
    Bostwick DG; Qian J
    Urology; 2001 Aug; 58(2 Suppl 1):91-3. PubMed ID: 11502458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.
    Hechtman JF; Xiao GQ; Unger PD; Kinoshita Y; Godbold JH; Burstein DE
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):344-9. PubMed ID: 22417861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma:  A Comparison With AMACR.
    Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
    Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.